The difference is that semaglutide is already FDA approved, widely prescribed, and proven to reduce both weight and cardiovascular risk
Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P et al (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma
(Source: Telehealth Ally, April 2026) What the Clinical Trials Actually Show The evidence base is strongest for semaglutide, with tirzepatide data still accumulating
Youre experiencing other symptoms : fatigue, cold intolerance, changes in your period, new acne or facial hair, or mood changes that could hint at thyroid or hormonal shifts
This makes it different from semaglutide (which mimics GLP-1) and tirzepatide (which mimics GLP-1 and GIP)
The testing culture sounds reassuring until you look at what the labs find